SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R
发明人:
DONG, ZHENG XIN,CULLER, MICHAEL DEWITT,SHEN, YEELANA,COMSTOCK, JEANNE MARY
申请号：
CA2625920
公开号：
CA2625920C
申请日:
2006.09.27
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
The invention comprises peptidyl analogs according to formulae (I) or (II) asdepicted below:(R2R3)-A1-A2-A3-A4-A5-A6-A7-A8-A9-A10-A11-A12-A13-A14-A15-A16-A17-A18-A19-A20-A21-A22-A23-A24-A25-A26-A27-A28R1wherein the definitions of A1 to A28 and R1 to R3 are provided for in thespecification for each of formulae (I) and (II),pharmaceutically acceptable salts thereof and pharmaceutical compositionscomprising an effective amount of a compound offormula (I), that possess agonist or antagonist ghrelin activity, along withtherapeutic and non-therapeutic uses thereof.
